when will tirzepatide be approved for Weight Loss Tirzepatide: First Approval | Drugs
Description
However, they may temporarily improve the skins appearance by making it seem more plump
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (Mounjaro) and chronic weight management (Zepbound) in adults
Others discover that they cannot reduce below a certain threshold without weight creeping back
Your experience with Wegovy, on the other hand, could be different
